Howmet Aerospace Inc vs Kymera Therapeutics Inc. Common Stock — how do they compare? Howmet Aerospace Inc trades at $217.54 (market cap $86.48B), while Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B). The key difference: Howmet Aerospace Inc is far larger — about 9.7× Kymera Therapeutics Inc. Common Stock's market cap, and Howmet Aerospace Inc pays a 0.26% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Howmet Aerospace Inc for 35 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| HWM | KYMR | |
|---|---|---|
Market Cap | $86.48B | $8.87B |
Volume | 3,558,498 | 779,107 |
Sector | Industrials | Health |
52-Week High | $292.65 | $127.31 |
52-Week Low | $189.68 | $55.80 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $90.58B | $8.26B |
Dividend Yield | 0.26% | — |
Signals from Pluang's Aura AI — not financial advice
Howmet Aerospace (HWM) trades at $216.84, down 1.8% with bearish technical signals despite strong fundamentals. The company has consistently beaten earnings estimates in recent quarters with Q2 2026 EPS of $1.33 exceeding expectations. Revenue growth continues with 2026 projections showing $9.1B revenue and 20.52% net margin. Analyst consensus remains strongly bullish with 84% buy ratings and $328.10 price target representing 51% upside potential.
The stock presents compelling growth potential driven by aerospace demand and defense modernization trends, though technical weakness and valuation concerns at 46.7x P/E warrant caution. Strong cash flow generation supports shareholder returns including dividends and buybacks, while supply chain risks and competitive pressures remain key watchpoints for investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →